Curiox Biosystems Co., Ltd (KOSDAQ:445680)

South Korea flag South Korea · Delayed Price · Currency is KRW
76,900
-7,700 (-9.10%)
At close: Apr 9, 2026
Market Cap1.32T +436.0%
Revenue (ttm)5.15B +12.3%
Net Income-27.18B
EPS-1,645.00
Shares Out17.12M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume164,135
Average Volume350,533
Open82,800
Previous Close84,600
Day's Range75,700 - 83,800
52-Week Range18,060 - 149,200
Beta2.80
RSI35.72
Earnings DateMay 15, 2026

About Curiox Biosystems

Curiox Biosystems Co., Ltd manufactures and sells automated equipment and consumables for cell analysis processes in South Korea. It offers C-FREE Pluto systems, including Pluto workstation, an Automated Antibody Cocktailing and Cell Staining in One Station; Pluto ALPHA, a Centrifuge-free cell washing; Pluto Code, a software script that brings Curiox’s centrifuge-free washing technology. The company offers other products & accessories, including C-FREE Gripper, C-FREE Tilter, DropArray Station, DropArray Bead Plates, MINI 1000 System, HT2100 Sy... [Read more]

Industry Surgical and Medical Instruments and Apparatus
Founded 2018
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 445680
Full Company Profile

Financial Performance

In 2025, Curiox Biosystems's revenue was 5.15 billion, an increase of 12.29% compared to the previous year's 4.59 billion. Losses were -27.18 billion, 236.0% more than in 2024.

Financial Statements